ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
13F holders, Q1 2021
Institutional positions in ImageneBio, Inc. as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- No complete 13F data for Q4 2020
- Shares held
- 19.3M
- No complete 13F data for Q4 2020
- Total value
- $538.5M
- No complete 13F data for Q4 2020
Holders and value by quarter
Institutions reporting IMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $36.8M |
| Q1 2026 | 39 | $26.8M |
| Q4 2025 | 41 | $32.9M |
| Q3 2025 | 33 | $38.3M |
| Q2 2025 | 41 | $42.6M |
| Q1 2025 | 46 | $41.9M |
| Q4 2024 | 53 | $52.0M |
| Q3 2024 | 57 | $49.1M |
| Q2 2024 | 70 | $47.9M |
| Q1 2024 | 57 | $42.7M |
| Q4 2023 | 54 | $63.8M |
| Q3 2023 | 58 | $141.6M |
| Q2 2023 | 52 | $204.7M |
| Q1 2023 | 39 | $86.2M |
| Q4 2022 | 34 | $69.9M |
| Q3 2022 | 42 | $93.2M |
| Q2 2022 | 46 | $118.7M |
| Q1 2022 | 48 | $167.8M |
| Q4 2021 | 49 | $343.6M |
| Q3 2021 | 39 | $271.8M |
| Q2 2021 | 42 | $293.2M |
| Q1 2021 | 27 | $538.5M |
Institutions, Q1 2021
Shares, value and share of portfolio for each institution holding ImageneBio, Inc..
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 970 | $27.0K | 0.00% | – | – |
| Maven Securities LTD | 9,805 | $248.0K | 0.02% | – | – |
| Hound Partners, LLC | 10,000 | $283.0K | 0.01% | – | – |
| Squarepoint Ops LLC | 13,759 | $389.0K | 0.00% | – | – |
| Credit Suisse AG | 24,422 | $690.0K | 0.00% | – | – |
| Polar Asset Management Partners Inc. | 28,738 | $812.0K | 0.01% | – | – |
| Goldman Sachs Group Inc | 39,100 | $1.10M | 0.00% | – | – |
| Vanguard Group Inc | 60,000 | $1.70M | 0.00% | – | – |
| Millennium Management LLC | 70,509 | $1.99M | 0.00% | – | – |
| BlackRock Inc. | 87,020 | $2.46M | 0.00% | – | – |
| Victory Capital Management Inc | 92,180 | $2.60M | 0.00% | – | – |
| Alyeska Investment Group, L.P. | 100,000 | $2.83M | 0.04% | – | – |
| Ensign Peak Advisors, Inc | 100,000 | $2.83M | 0.01% | – | – |
| Woodline Partners LP | 113,652 | $3.21M | 0.07% | – | – |
| Nantahala Capital Management, LLC | 325,000 | $9.18M | 0.52% | – | – |
| HealthCor Management, L.P. | 341,212 | $9.64M | 0.36% | – | – |
| Octagon Capital Advisors LP | 400,000 | $11.3M | 4.26% | – | – |
| Logos Global Management LP | 419,853 | $11.9M | 1.16% | – | – |
| Ra Capital Management, L.P. | 750,000 | $21.2M | 0.32% | – | – |
| CHI Advisors LLC | 814,756 | $23.0M | 4.61% | – | – |
| Farallon Capital Management, L.L.C. | 1,349,513 | $38.1M | 0.20% | – | – |
| Artal Group S.A. | 1,549,513 | $43.8M | 0.93% | – | – |
| BVF Inc | 1,599,658 | $45.2M | 1.69% | – | – |
| Citadel Advisors LLC | 2,053,068 | $58.0M | 0.06% | – | – |
| Omega Fund Management, LLC | 2,249,123 | $63.5M | 6.01% | – | – |
| OrbiMed Advisors LLC | 2,933,941 | $82.9M | 0.78% | – | – |
| FMR LLC | 3,777,638 | $99.7M | 0.01% | – | – |